177 related articles for article (PubMed ID: 29393466)
1. Upregulation of long non‑coding RNA CCAT2 indicates a poor prognosis and promotes proliferation and metastasis in intrahepatic cholangiocarcinoma.
Bai JG; Tang RF; Shang JF; Qi S; Yu GD; Sun C
Mol Med Rep; 2018 Apr; 17(4):5328-5335. PubMed ID: 29393466
[TBL] [Abstract][Full Text] [Related]
2. Long non‑coding RNA ZEB1‑AS1 predicts a poor prognosis and promotes cancer progression through the miR‑200a/ZEB1 signaling pathway in intrahepatic cholangiocarcinoma.
Jiao M; Ning S; Chen J; Chen L; Jiao M; Cui Z; Guo L; Mu W; Yang H
Int J Oncol; 2020 Jun; 56(6):1455-1467. PubMed ID: 32236578
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNA CCAT2 promotes cholangiocarcinoma cells migration and invasion by induction of epithelial-to-mesenchymal transition.
Xu Y; Yao Y; Qin W; Zhong X; Jiang X; Cui Y
Biomed Pharmacother; 2018 Mar; 99():121-127. PubMed ID: 29329034
[TBL] [Abstract][Full Text] [Related]
4. Blockade of CXCL12/CXCR4 signaling inhibits intrahepatic cholangiocarcinoma progression and metastasis via inactivation of canonical Wnt pathway.
Zhao S; Wang J; Qin C
J Exp Clin Cancer Res; 2014 Dec; 33(1):103. PubMed ID: 25471741
[TBL] [Abstract][Full Text] [Related]
5. Hepatoma-derived growth factor: a novel prognostic biomarker in intrahepatic cholangiocarcinoma.
Guo S; Liu HD; Liu YF; Liu L; Sun Q; Cui XJ
Tumour Biol; 2015 Jan; 36(1):353-64. PubMed ID: 25262276
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of lncRNA-NEF indicates poor prognosis in intrahepatic cholangiocarcinoma.
Liang Z; Zhu B; Meng D; Shen X; Li X; Wang Z; Li L
Biosci Rep; 2019 May; 39(5):. PubMed ID: 31015363
[TBL] [Abstract][Full Text] [Related]
7. High-mobility group box 1 expression and lymph node metastasis in intrahepatic cholangiocarcinoma.
Xu YF; Ge FJ; Han B; Yang XQ; Su H; Zhao AC; Zhao MH; Yang YB; Yang J
World J Gastroenterol; 2015 Mar; 21(11):3256-65. PubMed ID: 25805932
[TBL] [Abstract][Full Text] [Related]
8. Overexpressed long noncoding RNA Sox2ot predicts poor prognosis for cholangiocarcinoma and promotes cell proliferation and invasion.
Li Z; Li J; Ji D; Leng K; Xu Y; Huang L; Jiang X; Cui Y
Gene; 2018 Mar; 645():131-136. PubMed ID: 29246536
[TBL] [Abstract][Full Text] [Related]
9. Up-regulation of long non-coding RNA CCAT2 correlates with tumor metastasis and poor prognosis in cervical squamous cell cancer patients.
Chen X; Liu L; Zhu W
Int J Clin Exp Pathol; 2015; 8(10):13261-6. PubMed ID: 26722527
[TBL] [Abstract][Full Text] [Related]
10. The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis.
Huang S; Qing C; Huang Z; Zhu Y
Diagn Pathol; 2016 Jun; 11(1):49. PubMed ID: 27283598
[TBL] [Abstract][Full Text] [Related]
11. Up-regulated LINC00261 predicts a poor prognosis and promotes a metastasis by EMT process in cholangiocarcinoma.
Gao J; Qin W; Kang P; Xu Y; Leng K; Li Z; Huang L; Cui Y; Zhong X
Pathol Res Pract; 2020 Jan; 216(1):152733. PubMed ID: 31812439
[TBL] [Abstract][Full Text] [Related]
12. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma.
Yoshikawa D; Ojima H; Iwasaki M; Hiraoka N; Kosuge T; Kasai S; Hirohashi S; Shibata T
Br J Cancer; 2008 Jan; 98(2):418-25. PubMed ID: 18087285
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of nerve growth factor and tropomyosin-receptor-kinase signaling pathway in intrahepatic cholangiocarcinoma.
Yang XQ; Xu YF; Guo S; Liu Y; Ning SL; Lu XF; Yang H; Chen YX
World J Gastroenterol; 2014 Apr; 20(14):4076-84. PubMed ID: 24744599
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic biomarker for cholangiocarcinoma: circRNA Cdr1as.
Jiang XM; Li ZL; Li JL; Xu Y; Leng KM; Cui YF; Sun DJ
Eur Rev Med Pharmacol Sci; 2018 Jan; 22(2):365-371. PubMed ID: 29424892
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-21 regulates the invasion and metastasis in cholangiocarcinoma and may be a potential biomarker for cancer prognosis.
Huang Q; Liu L; Liu CH; You H; Shao F; Xie F; Lin XS; Hu SY; Zhang CH
Asian Pac J Cancer Prev; 2013; 14(2):829-34. PubMed ID: 23621247
[TBL] [Abstract][Full Text] [Related]
17. LncRNA CCAT2 predicts poor prognosis and regulates growth and metastasis in small cell lung cancer.
Chen S; Wu H; Lv N; Wang H; Wang Y; Tang Q; Shao H; Sun C
Biomed Pharmacother; 2016 Aug; 82():583-8. PubMed ID: 27470400
[TBL] [Abstract][Full Text] [Related]
18. SOX4 is associated with poor prognosis in cholangiocarcinoma.
Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S
Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339
[TBL] [Abstract][Full Text] [Related]
19. Low expression of ARID1A correlates with poor prognosis in intrahepatic cholangiocarcinoma.
Yang SZ; Wang AQ; Du J; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2016 Jul; 22(25):5814-21. PubMed ID: 27433094
[TBL] [Abstract][Full Text] [Related]
20. CD133 expression is a potential prognostic indicator in intrahepatic cholangiocarcinoma.
Shimada M; Sugimoto K; Iwahashi S; Utsunomiya T; Morine Y; Imura S; Ikemoto T
J Gastroenterol; 2010 Aug; 45(8):896-902. PubMed ID: 20379837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]